JPS58185165A - Ultrafiltration and filter dialysis type artificial kidney - Google Patents

Ultrafiltration and filter dialysis type artificial kidney

Info

Publication number
JPS58185165A
JPS58185165A JP57069895A JP6989582A JPS58185165A JP S58185165 A JPS58185165 A JP S58185165A JP 57069895 A JP57069895 A JP 57069895A JP 6989582 A JP6989582 A JP 6989582A JP S58185165 A JPS58185165 A JP S58185165A
Authority
JP
Japan
Prior art keywords
filtrate
blood
ultrafiltration
outlet
attached
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP57069895A
Other languages
Japanese (ja)
Inventor
佐藤公彦
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
HAYASHIMA KK
Original Assignee
HAYASHIMA KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by HAYASHIMA KK filed Critical HAYASHIMA KK
Priority to JP57069895A priority Critical patent/JPS58185165A/en
Publication of JPS58185165A publication Critical patent/JPS58185165A/en
Pending legal-status Critical Current

Links

Landscapes

  • External Artificial Organs (AREA)

Abstract

(57)【要約】本公報は電子出願前の出願データであるた
め要約のデータは記録されません。
(57) [Summary] This bulletin contains application data before electronic filing, so abstract data is not recorded.

Description

【発明の詳細な説明】 この発明は、(1) i透析患者の血液を平均孔径10
00人程度0多孔膜で限外濾過し、(2);その濾液を
平均孔径100X程度の多孔膜で限外濾過と透析とを同
時に行ない、(3) ; (1)のステップで限外濾過
を受けた血液と(2)のステップで限外濾過と透析とを
受けた濾液を混合し、患者の体内に戻すという新しいタ
イプの人工腎臓に関するものであって、従来の濾過型人
工腎臓に比べて有用な蛋白成分の損失を減少し、限外濾
過・透析効率を高くするとともに、所謂中分子量物の除
去性を高くすることを目的とするものである。
DETAILED DESCRIPTION OF THE INVENTION This invention provides (1) i.
Ultrafiltration is performed using a porous membrane with an average pore size of approximately 100X, (2); the filtrate is subjected to ultrafiltration and dialysis simultaneously through a porous membrane with an average pore diameter of approximately 100X, and (3); ultrafiltration is performed in step (1). This is a new type of artificial kidney that mixes the blood that has been received and the filtrate that has undergone ultrafiltration and dialysis in step (2) and returns it to the patient's body. The purpose of this invention is to reduce the loss of useful protein components, increase the efficiency of ultrafiltration and dialysis, and improve the removability of so-called medium molecular weight substances.

従来の透析型人工腎臓は、透析に使用する多孔膜の平均
孔径が約50X程度と小さいため、ニレミック トキシ
ン(Uremia Toxinθθ)の原因分質とされ
ている所謂中分子量物の除去性の低い欠点があった。
Conventional dialysis-type artificial kidneys have the disadvantage that the average pore diameter of the porous membrane used for dialysis is as small as approximately 50X, and the ability to remove so-called medium molecular weight substances, which are thought to be the causative substance of Uremia Toxin θθ, is low. there were.

なお従来の濾過型人工腎臓では、蛋白などの有用な成分
の損失が多く、また電解質などの補液の必要性があるな
どの欠点があった。
Conventional filtration-type artificial kidneys have disadvantages such as a large loss of useful components such as protein and the need for fluid replacement such as electrolytes.

この発明は、上記のような従来の欠点を改良する目的で
なされたものであって、下記のごとくである。
This invention was made for the purpose of improving the conventional drawbacks as described above, and is as follows.

すなわちこの発明は、平均孔径1000X程度の多孔膜
を設けた限外濾過器の上部と下部にそれぞれ血液流入口
と血液流出口を取付け、この血液流入口と穿刺針とを連
結する血液輸送管に血液ポンプを取付け、平均孔径10
0X程度の多孔膜を設けた限外濾過・透析器の上部と下
部にそれぞれ濾液流入口と濾液流出口を取付け、上記の
限外濾過器の側面に取付けた濾液流出口と限外濾過・透
析器の上部の濾液流入口を濾液輸送管で連結するととも
に、上記の限外濾過・透析器の側面に透析液流入口と透
析液流出口を取付け、限外濾過・透析器の下部の濾液流
出口に取伺けた濾液輸送管と前記の限外濾過器の下部の
血液流出口に取付けた血液輸送管とを、穿刺針を取付け
た血液・濾液輸送管に連結し、この連結部と限外濾過・
透析器の下部の濾液流出口の間の濾液輸送管に濾液ポン
プを取付けたことを特徴とするものである。
That is, this invention provides a blood inflow port and a blood outflow port respectively attached to the upper and lower parts of an ultrafilter provided with a porous membrane having an average pore diameter of about 1000X, and a blood transport tube connecting the blood inflow port and a puncture needle. Install blood pump, average pore size 10
A filtrate inlet and a filtrate outlet are installed at the top and bottom of an ultrafiltration/dialysis machine equipped with a porous membrane of approximately 0 The filtrate inlet at the top of the device is connected with a filtrate transport pipe, and the dialysate inlet and dialysate outlet are installed on the side of the ultrafiltration/dialysis machine, and the filtrate flow at the bottom of the ultrafiltration/dialysis machine is connected. Connect the filtrate transport pipe that reached the outlet and the blood transport pipe attached to the blood outflow port at the bottom of the ultrafilter to the blood/filtrate transport pipe to which the puncture needle was attached, and connect this connection to the ultrafilter. filtration·
It is characterized in that a filtrate pump is attached to the filtrate transport pipe between the filtrate outlet at the bottom of the dialyzer.

この発明は、上記のように構成されているので、この発
明の1実施例である第1図によりさらに詳細に説明すれ
ば下記のごとくである。
Since the present invention is constructed as described above, a more detailed explanation will be given below with reference to FIG. 1, which is an embodiment of the present invention.

1は平均孔径が100OX程度の多孔膜を設けた限外濾
過器であって、この限外濾過器1の上部と下部にそれぞ
れ血液流入口2と血液流出口3を取付けるとともに、こ
の限外濾過器1の側面の下部に濾液流出口4を取付けだ
ものである。
1 is an ultrafilter equipped with a porous membrane having an average pore diameter of about 100OX, and a blood inlet 2 and a blood outlet 3 are attached to the upper and lower parts of the ultrafilter 1, respectively. A filtrate outlet 4 is attached to the lower side of the vessel 1.

5は平均孔径が100x程度(100X以上が好ましい
)の多孔膜を設けた濾液の限外濾過・透析器であり、こ
の限外濾過・透析器5の上部と下部にそれぞれ濾液流人
口6と濾液流出ロアを取付けるとともに、限外濾過・透
析器5の側面に透析液流入口8と透析液流出口9を取付
けたものである。
5 is a filtrate ultrafiltration/dialysis machine equipped with a porous membrane with an average pore diameter of about 100x (preferably 100x or more), and a filtrate flow volume 6 and a filtrate flow are formed in the upper and lower parts of the ultrafiltration/dialysis machine 5, respectively. In addition to attaching an outflow lower, a dialysate inlet 8 and a dialysate outlet 9 are attached to the side of the ultrafiltration/dialyzer 5.

先端に穿刺針10を取付けた血液輸送管11の後端を前
記の限外濾過器1の上部の血液流入口2に連結し、この
血液輸送管11の中間に血液ポンプ12を取付けるとと
もに、この限外濾過器1の側面の濾液流出口4と前記の
限外濾過・透析器5の上部の濾液流人口6とを濾液輸送
管13で連結し、さらに限外濾過器1の下部の血液流出
口3に連結した血液輸送管14と限外濾過・透析器5の
下部の濾液流出ロアに連結した濾液輸送管15のそれぞ
れの他端を、穿刺針16を一端に取付けた血液・濾液輸
送管17の他端に連結するとともに、この連結部と前記
の限外濾過・透析器の下部の濾液流出ロアとの間の濾液
輸送管15に濾液ポンプ18を取付け、限外濾過・透析
器5の側面の透析液流入口8および透析液流出口9と透
析液供給装置(図示せず)との間にそれぞれ透析液輸送
管19.20を取付けたものである。
The rear end of a blood transport tube 11 with a puncture needle 10 attached to its tip is connected to the blood inlet 2 at the top of the ultrafilter 1, and a blood pump 12 is installed in the middle of this blood transport tube 11. The filtrate outlet 4 on the side of the ultrafilter 1 and the filtrate flow port 6 at the upper part of the ultrafilter/dialyzer 5 are connected by a filtrate transport pipe 13, and the blood flow at the lower part of the ultrafilter 1 is connected. The other ends of the blood transport pipe 14 connected to the outlet 3 and the filtrate transport pipe 15 connected to the filtrate outflow lower portion at the bottom of the ultrafiltration/dialyzer 5 are connected to a blood/filtrate transport pipe with a puncture needle 16 attached to one end. 17, and a filtrate pump 18 is attached to the filtrate transport pipe 15 between this connection and the filtrate outflow lower at the bottom of the ultrafiltration/dialyzer 5. Dialysate transport pipes 19 and 20 are respectively installed between the dialysate inlet 8 and dialysate outlet 9 on the side and a dialysate supply device (not shown).

この発明は上記のように構成されているので、下記のよ
うな作用がある。
Since the present invention is configured as described above, it has the following effects.

血液ポンプ12の吸引作用により穿刺針10から流入し
た血液(動脈血)は、゛血液輸送管11を通り限外濾過
器1の上部の血液流入口2からこの限外濾過器1の多孔
膜(図示せず)の中に流入する。
Blood (arterial blood) flowing from the puncture needle 10 due to the suction action of the blood pump 12 passes through the blood transport tube 11 and passes through the blood inlet 2 at the top of the ultrafilter 1 to the porous membrane of the ultrafilter 1 (Fig. (not shown).

この多孔膜の中を流下する間に、多孔膜の内部と外部と
の間の化学ポテンシャルの差、すなわちこの多孔膜内外
の圧力差を利用して、血液の中の水分や老慶物などの代
謝産物を多孔膜の外に移動して除去する。この限外濾過
器1の多孔膜は平均径が1000X程度と非常に大きい
ので、従来の血液透析器(従来は一般に平均孔径が50
1程度の多孔膜が設けられている。)により多孔膜外に
移動させ分離する物質よりも大きな分子(中分子)を多
孔膜外に移動させ分離することができる。このように血
液が限外濾過器1で濾過され清浄になって、限外濾過器
1の下部の血液流出口6から血液輸送管14内に流出す
る。
While flowing through this porous membrane, the difference in chemical potential between the inside and outside of the porous membrane, that is, the pressure difference between the inside and outside of the porous membrane, is used to remove water and old substances in the blood. Metabolites are moved out of the porous membrane and removed. The porous membrane of this ultrafilter 1 has a very large average diameter of about 1000X, so conventional hemodialyzers (conventional devices generally have an average pore diameter of 50X)
A porous membrane of about 1 is provided. ), it is possible to move molecules larger than the substance to be separated (middle molecules) out of the porous membrane and separate them. In this way, the blood is filtered and purified by the ultrafilter 1, and flows out into the blood transport tube 14 from the blood outlet 6 at the bottom of the ultrafilter 1.

この限外濾過器1内に設けた平均孔径1000 ’h程
度の多孔膜中を流動する血液から分離され多孔膜外に移
動した濾液は、この限外濾過器1の側面の下部に取付け
た濾液流出口4から流出し、濾液輸送管13を通り濾液
流人口6から限外濾過・透析器5に設けた平均孔径10
0 X程度(100λ以上が好ましい)の多孔膜(図示
せず)内に流入し、この限外濾過・透析器5の下部の濾
液流出ロアから濾液輸送管15内に流出する。
The filtrate that is separated from the blood flowing through the porous membrane with an average pore diameter of about 1000'h provided in this ultrafilter 1 and moved outside the porous membrane is the filtrate attached to the lower part of the side of this ultrafilter 1. The filtrate flows out from the outlet 4 and passes through the filtrate transport pipe 13 from the filtrate flow port 6 to the average pore diameter 10 provided in the ultrafiltration/dialyzer 5.
It flows into a porous membrane (not shown) with a diameter of about 0.times.

透析液供給装置(図示せず)から流出する透析液は、透
析液輸送管19を通り透析液流入口8から濾液濾過・透
析器5内に流入し、限外濾過・透析器5の中を施回した
のち透析液流出口9から流出し、透析液輸送管20内を
通って透析液排出口(図示せず)から排出除去される。
The dialysate flowing out from the dialysate supply device (not shown) passes through the dialysate transport pipe 19 and flows into the filtrate filtration/dialysis machine 5 from the dialysate inlet 8, and then flows through the ultrafiltration/dialysis machine 5. After the treatment, the dialysate flows out from the dialysate outlet 9, passes through the dialysate transport pipe 20, and is discharged and removed from the dialysate outlet (not shown).

 透析液が限外濾過・透析器5内を施回する間に、限外
濾過・透析器5内に設けた多孔膜内を流下する濾液から
、このits中の水分や代謝産物を多孔膜外に移動させ
分離除去する。この限外濾過・透析器5では、平均孔径
が100 X程度(100又以上が好ましい)の多孔膜
で上記のように濾液の限外濾過と透析とが同時に実施さ
れる。
While the dialysate is being passed through the ultrafiltration/dialysis machine 5, the water and metabolites in it are removed from the filtrate flowing down through the porous membrane provided in the ultrafiltration/dialysis machine 5 outside the porous membrane. to separate and remove. In this ultrafiltration/dialyzer 5, ultrafiltration and dialysis of the filtrate are simultaneously performed as described above using a porous membrane having an average pore diameter of about 100× (preferably 100× or more).

なお濾液中の蛋白質は除去されない。Note that proteins in the filtrate are not removed.

この限外濾過・透析器5では濾液のみを濾過・透析する
ので、従来のように全血液を透析する血液透析の場合よ
りも粘性が低くなり、血液の限外濾過・透析の効率が高
くなる。 まだ従来の濾過型人工腎臓に比べては、蛋白
質などの有用な成分の損失がほとんどなく、電解質など
の補液の必要性もなくなる。
Since this ultrafiltration/dialysis machine 5 filters and dialyzes only the filtrate, the viscosity is lower than in the case of conventional hemodialysis in which whole blood is dialyzed, and the efficiency of blood ultrafiltration/dialysis is higher. . Compared to conventional filtering artificial kidneys, there is almost no loss of useful components such as protein, and there is no need for replacement fluids such as electrolytes.

このようにして限外濾過と透析とを同時に実施された濾
液は濾液流出ロアから流出し、濾液輸送管15を通り、
血液濾液輸送管17内に流出して、血液輸送管14から
血液濾液輸送管17内に流出してきた血液と混合され穿
刺針16から静脈内に流出する。
The filtrate subjected to ultrafiltration and dialysis simultaneously flows out from the filtrate outflow lower, passes through the filtrate transport pipe 15,
The blood flows out into the blood filtrate transport pipe 17, mixes with the blood that has flowed out into the blood filtrate transport pipe 17 from the blood transport pipe 14, and flows out from the puncture needle 16 into the vein.

なお限外濾過器1内で血液が濾過される程度は血液ポン
プ12の加圧の調節によって行ない、この限タト瀘過器
1で濾過された濾液は、限4F濾過・透析器5内に流入
し、この限外濾過・透析器5内で濾液が限外濾過と透析
と同時に行われる程度は透析液側の負圧の調節によって
行なうことができる。
The extent to which blood is filtered within the ultrafilter 1 is controlled by adjusting the pressurization of the blood pump 12, and the filtrate filtered through the ultrafilter 1 flows into the ultrafilter 5. However, the extent to which the filtrate is subjected to ultrafiltration and dialysis simultaneously in the ultrafiltration/dialyzer 5 can be controlled by adjusting the negative pressure on the dialysate side.

この発明は上記のような作用があるので、下記のような
効果がある。
Since this invention has the above-mentioned functions, it has the following effects.

(a)  従来の濾過型人工腎臓で問題となる蛋d%ど
有用な成分の損失がほとんどなく、また電解質などの補
液の必要性がなくなる。
(a) There is almost no loss of useful components such as protein d%, which is a problem with conventional filtering artificial kidneys, and there is no need for replacement fluids such as electrolytes.

(b)  従来の透析型人工腎臓に比べ、全血液から限
外濾過した濾液成分を限外濾過・透析するため、濾液の
粘性が低くなり、全血液を透析する方法よりも限外濾過
・透析の効率が高い。
(b) Compared to conventional dialysis-type artificial kidneys, the filtrate component that has been ultrafiltered from whole blood is ultrafiltered and dialysed, so the viscosity of the filtrate is lower, making it easier to use ultrafiltration and dialysis than methods that dialyze whole blood. High efficiency.

(C)  従来の透析型人工腎臓に使用している平均孔
径が約50X程度の多孔膜に比べ、より大きい平均孔径
の100X8度と1000^程度の多孔膜をそれぞれ使
用しているため、所謂中分子量物(Uremia To
xi、nee)の原因分質とされている)の除去性が高
くなる。
(C) Compared to the porous membrane with an average pore diameter of about 50X used in conventional dialysis-type artificial kidneys, we use porous membranes with a larger average pore diameter of about 100X and 1000^, respectively, so the so-called medium pore diameter is used. Molecular weight substances (Uremia To
xi, nee)), which are considered to be the causative substances, becomes more removable.

などの顕著な効果がある。There are significant effects such as

【図面の簡単な説明】[Brief explanation of drawings]

第1図はこの発明の概要を示す説明図である。 1・・・・・・限外濾過器 2・・・・・・血液流入口 6・・・・・・血液流出口 4.7・・・・・・濾液流出口 5・・・・・・限外濾過・透析器 6・・・・・・濾液流入口 8・・・・・・透析液流入口 9・・・・・・透析液流出口 10.16・・・・・・穿刺例 11.14・・・・・・血液輸送管 12・・・・・・血液ポンプ 16.15・・・・・・濾液輸送管 17・・・・・・血液濾液輸送管 18・・・・・・濾液ポンプ 19.20・・・・・・透析液輸送管 FIG. 1 is an explanatory diagram showing an outline of the invention. 1... Ultrafilter 2...Blood inlet 6...Blood outflow port 4.7...Filtrate outlet 5... Ultrafiltration/dialysis machine 6...Filtrate inlet 8... Dialysate inlet 9... Dialysate outflow port 10.16...Puncture example 11.14・・・Blood transport tube 12・・・Blood pump 16.15...Filtrate transport pipe 17...Blood filtrate transport tube 18...Filtrate pump 19.20... Dialysate transport tube

Claims (1)

【特許請求の範囲】[Claims] 平均孔径1000λ程度の多孔膜を設けた限外濾過器の
上部と下部にそれぞれ血液流入口と血液流出口を取付け
、この血液流入口と穿刺針とを連結する血液輸送管に血
液ポンプを取付け、平均孔径100X程度の多孔膜を設
けた限外濾過・透析器の上部と下部にそれぞれ濾液流入
口と濾液流出口を取付け、上記の限外濾過器の側面に取
付けた濾液流出口と限外濾過・透析器の上部の濾液流入
口を濾液輸送管で連結するとともに、上記の限外濾過・
透析器の側面に透析液流入口と透析液流出口を取付け、
限外濾過・透析器の下部の濾液流出口に取付けた濾液輸
送管と前記の限外濾過器の下部の血液流出口に取付けた
血液輸送管とを、穿刺針を取付けた血液・濾液輸送管に
連結し、この連結部と限外濾過・透析器の下部の濾液流
出口の間の濾液輸送管に濾液ポンプを取付けたことを特
徴とする限外濾過・濾過透析型人工腎臓。
A blood inlet and a blood outlet are attached to the upper and lower parts of an ultrafilter equipped with a porous membrane with an average pore diameter of about 1000λ, respectively, and a blood pump is attached to the blood transport tube connecting the blood inlet and the puncture needle. A filtrate inlet and a filtrate outlet are attached to the upper and lower parts of an ultrafiltration/dialyzer equipped with a porous membrane with an average pore diameter of approximately 100X, respectively, and a filtrate outlet and an ultrafiltration outlet attached to the side of the ultrafilter are・Connect the filtrate inlet at the top of the dialyzer with a filtrate transport pipe, and connect the above ultrafiltration
Attach the dialysate inlet and dialysate outlet to the side of the dialyzer.
The filtrate transport pipe attached to the filtrate outlet at the bottom of the ultrafiltration/dialysis machine and the blood transport pipe attached to the blood outlet at the bottom of the ultrafilter are connected to a blood/filtrate transport pipe with a puncture needle attached. An ultrafiltration/filtration dialysis type artificial kidney, characterized in that a filtrate pump is attached to a filtrate transport pipe between this connection part and a filtrate outlet at the bottom of the ultrafiltration/dialysis machine.
JP57069895A 1982-04-26 1982-04-26 Ultrafiltration and filter dialysis type artificial kidney Pending JPS58185165A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP57069895A JPS58185165A (en) 1982-04-26 1982-04-26 Ultrafiltration and filter dialysis type artificial kidney

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP57069895A JPS58185165A (en) 1982-04-26 1982-04-26 Ultrafiltration and filter dialysis type artificial kidney

Publications (1)

Publication Number Publication Date
JPS58185165A true JPS58185165A (en) 1983-10-28

Family

ID=13415896

Family Applications (1)

Application Number Title Priority Date Filing Date
JP57069895A Pending JPS58185165A (en) 1982-04-26 1982-04-26 Ultrafiltration and filter dialysis type artificial kidney

Country Status (1)

Country Link
JP (1) JPS58185165A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61172563A (en) * 1984-11-16 1986-08-04 アニサ メデイカル インコ−ポレ−テツド Method and system for removing immune reaction suppressing component from blood of mammal

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61172563A (en) * 1984-11-16 1986-08-04 アニサ メデイカル インコ−ポレ−テツド Method and system for removing immune reaction suppressing component from blood of mammal

Similar Documents

Publication Publication Date Title
US8398859B2 (en) Haemodialfiltration method and apparatus
US5011607A (en) Hemodiafiltration system
US9713668B2 (en) Multi-staged filtration system for blood fluid removal
JP3695506B2 (en) Dialysis machine and washing priming method
US6719907B2 (en) Dual-stage filtration cartridge
JP4091873B2 (en) Dialysis machine
RU2007134365A (en) SYSTEM AND METHOD FOR LIQUID REGENERATION
JPS63150076A (en) Apparatus for drawing out fluids from patient
SU553912A3 (en) Artificial kidney
EP1604699A3 (en) Device and method for controlling infusion of a liquid in an extracorporeal blood circuit
JPH05192399A (en) Artificial kidney and its control method
US11931499B2 (en) Pressure detector
US5498340A (en) Processing of protein-containing body fluids
JP2001245970A (en) Priming processing method for blood circuit
JP3858260B2 (en) Blood purification equipment
JP2543466Y2 (en) Body fluid filtration and concentration device
CN108697987A (en) System and method for filtering fluid
CN204379871U (en) A kind of hemoperfusion cascading hemodialysis filtration system
JPS58185165A (en) Ultrafiltration and filter dialysis type artificial kidney
JP2961481B2 (en) Hemodialyzer and hemofilter
JPS6315860B2 (en)
JP2002095740A (en) Method for returning residual blood in blood circuit and device for blood purification
CN218356829U (en) Extracorporeal circulation connecting pipe for hemodialysis
JP4097105B2 (en) Method for operating hemodialyzer and hemodialyzer
JPS596663B2 (en) Multi-stage filtration/reabsorption artificial kidney